Affordable Access

Publisher Website

The role of −850 tumor necrosis factor-α and apolipoprotein E genetic polymorphism in patients with Down's syndrome-related dementia

Authors
Journal
Neuroscience Letters
0304-3940
Publisher
Elsevier
Publication Date
Volume
352
Issue
1
Identifiers
DOI: 10.1016/j.neulet.2003.08.021
Keywords
  • Down'S Syndrome
  • −850 Tumor Necrosis Factor-α
  • Apolipoprotein E
  • Polymorphisms
  • Risk Of Dementia
  • Association Studies
Disciplines
  • Biology
  • Logic
  • Medicine

Abstract

Abstract Down's syndrome (DS) is a disease with a complex etiology. It is likely that other factors besides genes located on chromosome 21 may play a role in clinical features of affected patients. Tumor necrosis factor-α (TNF-α) (6p21.3) and apolipoprotein E (APOE) (19q13.2) are candidate genes as they interact with the brain deposition of Aβ, one of the neuropathological hallmarks in DS. We examined 136 DS patients and 113 controls for −850 TNF-α and APOE polymorphisms. The −850T frequency in DS was significantly higher than in controls ( P<0.005, OR 2.05, 95% CI 1.22–3.49) while the APOE E4 allele was negatively selected in patients compared to normal subjects ( P<0.005, OR 0.38, 95% CI 0.20–0.71). Our findings suggest that the −850T allele, which is more common among patients at high risk of dementia such as those with DS, might eventually play a role in the development of dementia; no inference on the role of the allele APOE E4 in DS-related dementia may be derived from our results.

There are no comments yet on this publication. Be the first to share your thoughts.